11/01/2026
💗 This is the kind of news that gives us hope.
A promising new treatment for advanced breast cancer is showing encouraging results, with tumors shrinking in approximately 75% of patients in a recent clinical trial.
Even more encouraging, the treatment helped keep the cancer from progressing significantly longer than traditional chemotherapy.
While more research is needed, and the treatment does come with risks and side effects, advances like these remind us why continued breast cancer research matters so much.
For those living with metastatic breast cancer, more treatment options and more time without disease progression can mean so much.
At the North Fork Breast Health Coalition, we celebrate every step forward in research and remain committed to supporting those affected by breast cancer, every step of the way.
Progress matters. Hope matters. And every patient matters.
Read the encouraging news below. ⬇️
A phase 3 clinical trial published in JAMA found trastuzumab rezetecan linked to 73% lower risk of cancer progression or death versus chemotherapy.